Phase II study of FK228 in patients with metastatic hormone refractory prostate cancer (HRPC)

被引：0

作者：

Molife, Rhoda

Dearnaley, David

Parker, Chris

Patterson, Stephen

Riggs, Charles

Higano, Celestia

Stadler, William M.

McCulloch, William

Shalaurov, Alex

de Bono, Johann

机构：

[1] Royal Marsden Hosp, Drug Dev Unit, Sutton SM2 5NG, Surrey, England

[2] Royal Marsden Hosp, Acad Urol Unit, Sutton SM2 5NG, Surrey, England

[3] Univ S Florida, H Lee Moffitt Canc Ctr, Genitourinary Oncol Program, Tampa, FL 33682 USA

[4] Univ Florida, Dept Med, Gainesville, FL 32611 USA

[5] Seattle Canc Care Alliance, Seattle, WA USA

[6] Univ Chicago, Chicago, IL 60637 USA

[7] Gloucester Pharmaceut Inc, Med & Regulatory, Cambridge, MA USA

[8] Charles Rivers Labs, Cary, NC USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：149 / 149

页数：1